Boston Scientific
Open
$46.90
Prev. Close
$46.90
High
$46.97
Low
$46.85
Market Snapshot
$69.62B
19.5
1.26
$16.75B
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 59,000 full-time employees. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 59,000 full-time employees. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
Recently from Cashu
Boston Scientific Faces Sales Slowdown and Competition Challenges with Watchman Device
Boston Scientific (Ticker: BSX) is navigating a challenging environment in the medical device market, particularly highlighted by recent challenges with its Watchman device product line. The company h…
Boston Scientific's SEISMIQ 4CE Trial Provides Hope for Calcified Coronary Artery Disease Treatment
Boston Scientific Corporation (Ticker: BSX) announces significant findings from its pivotal SEISMIQ 4CE trial, marking a noteworthy advancement in the treatment of severely calcified coronary artery d…
Boston Scientific Invests $1.5 Billion in MiRus for TAVR Market Expansion and Innovation
Boston Scientific Corporation has made a significant strategic investment of $1.5 billion in MiRus LLC, aimed at expanding its footprint in the transcatheter aortic valve replacement (TAVR) market. Th…
Boston Scientific Enhances Capital Strategy with 10 Million Share Offering for Employee Ownership Plan
Boston Scientific Corporation (Ticker: BSX) is taking strategic steps to enhance its capital allocation strategy through a recent filing of a shelf registration for offering 10,000,000 shares of commo…